MDRX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into Veradigm Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

Robbins Geller Rudman & Dowd LLP, a renowned law firm specializing in complex class action cases, is currently investigating potential violations of U.S. federal securities laws involving Veradigm Inc. (NASDAQ:MDRX). The investigation focuses on whether Veradigm and certain top executives made false or misleading statements, as well as failed to disclose material information to investors.

Veradigm, a leading healthcare technology company, provides a range of solutions to over 300,000 U.S. healthcare providers, including electronic health records, financial management, population health management, and consumer solutions.

The investigation stems from recent revelations made by Veradigm. On February 28, 2023, the company announced the detection of internal control failures related to revenue recognition over the past six quarters, resulting in misstatements to reported revenues during those periods. Subsequently, on March 22, 2023, Veradigm disclosed that it expects to report one or more material weaknesses as of December 31, 2022, along with its remediation efforts. The weaknesses are related to revenue recognition and certain non-routine review controls. Veradigm also acknowledged the ineffectiveness of its disclosure controls and procedures, as well as its internal control over financial reporting as of December 31, 2022.

Further adding to the situation, on June 13, 2023, Veradigm revealed the identification of additional revenue misstatements dating back to fiscal 2020. The company expects to restate previously reported results for 2021 and 2022, with an estimated reduction of revenue from continuing operations of approximately $40 million. A portion of this impact is anticipated to relate to the year 2020.

Robbins Geller, known for its expertise in securities fraud cases, is ranked number one on the ISS Securities Class Action Services Top 50 Report for recovering over $1.75 billion for investors in 2022. This marks the third consecutive year that Robbins Geller has topped the list. In total, the firm has recovered nearly $5.3 billion for investors in the past three years, surpassing any other plaintiffs’ firm. With 200 lawyers across 10 offices, Robbins Geller is one of the largest plaintiffs’ firms globally, having secured some of the largest securities class action recoveries in history.

While the investigation is ongoing, Veradigm and its offerings remain highly regarded in the healthcare technology sector. The company’s commitment to providing electronic health records, financial management, population health management, and consumer solutions to healthcare providers has been instrumental in improving the efficiency and effectiveness of healthcare delivery.

It is important to note that attorney advertising and past results do not guarantee future outcomes. The services provided by Robbins Geller may be performed by attorneys in any of their offices.

For more information about Robbins Geller and their services in securities fraud litigation, please visit their website.

Source: [Business Wire](https://www.businesswire.com/news/home/20231006112926/en/)